Advances in the Treatment of Fragile X Syndrome

被引:401
作者
Hagerman, Randi J. [1 ,2 ]
Berry-Kravis, Elizabeth [4 ,5 ,6 ]
Kaufmann, Walter E. [7 ]
Ono, Michele Y. [1 ,2 ]
Tartaglia, Nicole [8 ]
Lachiewicz, Ave [9 ,10 ]
Kronk, Rebecca [11 ,12 ]
Delahunty, Carol [13 ]
Hessl, David [1 ,3 ]
Visootsak, Jeannie [14 ,15 ]
Picker, Jonathan [16 ,17 ]
Gane, Louise [1 ,2 ]
Tranfaglia, Michael [18 ]
机构
[1] Univ Calif Davis, Sch Med, MIND Inst, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA
[3] Univ Calif Davis, Sch Med, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA
[4] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA
[5] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
[6] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA
[7] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Ctr Genet Disorders Cognit & Behav, Baltimore, MD 21205 USA
[8] Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA
[9] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[10] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA
[11] Univ Pittsburgh, Dept Educ Psychol, Pittsburgh, PA USA
[12] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA
[13] Akron Childrens Hosp, Neurodev Ctr, Akron, OH USA
[14] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA
[15] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA
[16] Childrens Hosp, Dept Genet, Boston, MA 02115 USA
[17] Childrens Hosp, Dept Child & Adolescent Psychiat, Boston, MA 02115 USA
[18] FRAXA Res Fdn, Newburyport, MA USA
基金
美国国家卫生研究院;
关键词
fragile X syndrome; autism; behavioral interventions; fragile X mental retardation protein; targeted treatments; fenobam; MENTAL-RETARDATION PROTEIN; PERVASIVE DEVELOPMENTAL DISORDERS; DEFICIT HYPERACTIVITY DISORDER; SEROTONIN REUPTAKE INHIBITORS; FMR1; MESSENGER-RNA; ATTENTION-DEFICIT; MOUSE MODEL; SYNAPTIC PLASTICITY; DOUBLE-BLIND; TREMOR/ATAXIA SYNDROME;
D O I
10.1542/peds.2008-0317
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The FMR1 mutations can cause a variety of disabilities, including cognitive deficits, attention-deficit/hyperactivity disorder, autism, and other socioemotional problems, in individuals with the full mutation form (fragile X syndrome) and distinct difficulties, including primary ovarian insufficiency, neuropathy and the fragile X-associated tremor/ataxia syndrome, in some older premutation carriers. Therefore, multigenerational family involvement is commonly encountered when a proband is identified with a FMR1 mutation. Studies of metabotropic glutamate receptor 5 pathway antagonists in animal models of fragile X syndrome have demonstrated benefits in reducing seizures, improving behavior, and enhancing cognition. Trials of metabotropic glutamate receptor 5 antagonists are beginning with individuals with fragile X syndrome. Targeted treatments, medical and behavioral interventions, genetic counseling, and family supports are reviewed here. Pediatrics 2009;123:378-390
引用
收藏
页码:378 / 390
页数:13
相关论文
共 193 条
[91]   Social behavior and cortisol reactivity in children with fragile X syndrome [J].
Hessl, David ;
Glaser, Bronwyn ;
Dyer-Friedman, Jennifer ;
Reiss, Allan L. .
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2006, 47 (06) :602-610
[92]  
Hills-Epstein J. L., 2002, FRAGILE X SYNDROME D, P339
[93]   A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism [J].
Hollander, E ;
Phillips, A ;
Chaplin, W ;
Zagursky, K ;
Novotny, S ;
Wasserman, S ;
Iyengar, R .
NEUROPSYCHOPHARMACOLOGY, 2005, 30 (03) :582-589
[94]   GUANFACINE FOR TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN BOYS [J].
HORRIGAN, JP ;
BARNHILL, LJ .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 1995, 5 (03) :215-223
[95]   Altered synaptic plasticity in a mouse model of fragile X mental retardation [J].
Huber, KM ;
Gallagher, SM ;
Warren, ST ;
Bear, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (11) :7746-7750
[96]   AN OPEN TRIAL OF GUANFACINE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER [J].
HUNT, RD ;
ARNSTEN, AFT ;
ASBELL, MD .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1995, 34 (01) :50-54
[97]   Epilepsy in fragile X syndrome [J].
Incorpora, G ;
Sorge, G ;
Sorge, A ;
Pavone, L .
BRAIN & DEVELOPMENT, 2002, 24 (08) :766-769
[98]   The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders - A case series [J].
Ingrassia, A ;
Turk, J .
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2005, 14 (01) :34-40
[99]   Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice [J].
Irwin, SA ;
Idupulapati, M ;
Gilbert, ME ;
Harris, JB ;
Chakravarti, AB ;
Rogers, EJ ;
Crisostomo, RA ;
Larsen, BP ;
Mehta, A ;
Alcantara, CJ ;
Patel, B ;
Swain, RA ;
Weiler, IJ ;
Oostra, BA ;
Greenough, WT .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 111 (02) :140-146
[100]  
ITIL TM, 1978, CURR THER RES CLIN E, V24, P708